Neurocisticercosis en niños

Autores:
González Velásquez, Tania
Barboza Ubarnes, Miriam
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad de Cartagena
Repositorio:
Repositorio Universidad de Cartagena
Idioma:
spa
OAI Identifier:
oai:repositorio.unicartagena.edu.co:11227/13338
Acceso en línea:
https://hdl.handle.net/11227/13338
https://doi.org/10.32997/rcb-2011-3069
Palabra clave:
Cisticercosis. Neurocisticercosis. Taenia solium.
Rights
openAccess
License
Revista Ciencias Biomédicas - 2020
id UCART2_a160a12d2f5b178ceccbce7a57c018b6
oai_identifier_str oai:repositorio.unicartagena.edu.co:11227/13338
network_acronym_str UCART2
network_name_str Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv Neurocisticercosis en niños
dc.title.translated.eng.fl_str_mv Neurocisticercosis en niños
title Neurocisticercosis en niños
spellingShingle Neurocisticercosis en niños
Cisticercosis. Neurocisticercosis. Taenia solium.
title_short Neurocisticercosis en niños
title_full Neurocisticercosis en niños
title_fullStr Neurocisticercosis en niños
title_full_unstemmed Neurocisticercosis en niños
title_sort Neurocisticercosis en niños
dc.creator.fl_str_mv González Velásquez, Tania
Barboza Ubarnes, Miriam
dc.contributor.author.spa.fl_str_mv González Velásquez, Tania
Barboza Ubarnes, Miriam
dc.subject.spa.fl_str_mv Cisticercosis. Neurocisticercosis. Taenia solium.
topic Cisticercosis. Neurocisticercosis. Taenia solium.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-12-21 00:00:00
dc.date.available.none.fl_str_mv 2020-12-21 00:00:00
dc.date.issued.none.fl_str_mv 2020-12-21
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv Journal article
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 2215-7840
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/11227/13338
dc.identifier.doi.none.fl_str_mv 10.32997/rcb-2011-3069
dc.identifier.eissn.none.fl_str_mv 2389-7252
dc.identifier.url.none.fl_str_mv https://doi.org/10.32997/rcb-2011-3069
identifier_str_mv 2215-7840
10.32997/rcb-2011-3069
2389-7252
url https://hdl.handle.net/11227/13338
https://doi.org/10.32997/rcb-2011-3069
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.ispartofjournal.spa.fl_str_mv Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3069/2600
dc.relation.citationedition.spa.fl_str_mv Núm. 2 , Año 2011
dc.relation.citationendpage.none.fl_str_mv 296
dc.relation.citationissue.spa.fl_str_mv 2
dc.relation.citationstartpage.none.fl_str_mv 289
dc.relation.citationvolume.spa.fl_str_mv 2
dc.relation.references.spa.fl_str_mv Garcia H, Brutto O. For the cisticercosis working Groupin Perú. Neurocysticercosis:Updated concepts about and old disease. Lancet Neurol 2005;4: 653-61.
Agudelo P, Botero D, Palacio G. Evaluación del método de ELISA de punto para el diagnóstico de la cisticercosis humana y para estimar valores de prevalencia en una región endémica en Colombia. Biomédica. 2005; 25: 40-43.
Flórez AC, Rojas R, Montero YA. Estudio retrospectivo de seroprevalencia de Neurocisticercosis en pacientes colombianos que acudieron al Instituto Nacional de Salud, durante un período de 10 años (1995 – 2005). Programa de Vigilancia por el Laboratorio. Infectio 2006 10(2): 98
Bonelo A, Carvajal H. Cisticercosis en pacientes con cuadro neurológico en Cali, Facultad de Salud, Universidad del Valle, Cali. Biomédica. Santa Fe de Bogotá Suplemento jul. 1993; 96
Vasquez L, Ortiz J, Velasco A, González F. Neurocisticercosis: casos clínicos presentes en el hospital universitario San José Popayán, 1994 – 1999. Infect. 2000, 4, (1): 51-52.
Sanzón A. Prevalencia de anticuerpos contra cisticercos. Colombia médica Cali, 1991; 22: 98- 100.
Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-1734.
Giménez-Roldán S, Díaz F, Esquivel A. Neurocisticercosis e inmigración. Neurología 2003; 18: 385-388.
Pal DK, Carpio A, Sander JWAS. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000; 68; 137-143.
Kalra V, Sethi A. childhood neurocysticercosis – epidemiology diagnosis and course. Acta Peaditr Jpn, 1992, 34 :365-70
Aguilar F. Perfil de la neurocisticercosis en niños mexicanos. Cir Ciruj 1998; 66:86-89.
Gaffo AL, Guillen-Pinto D, Campos-Olazábal P, Burneo JG. Cisticercosis, la causa principal de crisis parciales en niños en Peru. Rev Neurol 2004; 39: 924-926.
Hauser WA, Pellock JM Dodson WE. Epidemiology of epilepsy in children. Pediatric epilepsy: diagnosis and therapy. 2001;12: 81-96.
Carod-Artal F. Causas tropicales de epilepsia.Rev Neurol 2009;49:475-82
Botero D, Restrepo M. Parasitosis humana. Editorial Colombia Corporación Para La Investigaciones Biológicas; 4rt edición. Medellín, Colombia.2003.
Sighi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Chil Neurol 2000; 15: 207-213.
Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimora S. Neurocysticercosis in children: clinical study and follow-up of 112 patients. Rev Neurol 2006; 42 Supl 3: 97-101.
Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM. Clinical aspects of neurocisticercosis in children. Pediatr Neurol 2000; 22: 287-289.
Ruiz-García M. Neurocysticercosis in children. Clinical experience in 122 patients. Child Nerv Syst 1997; 13: 608-612.
Cuéllar R, Molinero M, Ramírez F, Vallejo V. Manifestaciones clínicas de la neurocisticercosis cerebral activa en pediatría. Rev Neurol 1999; 29: 334-337.
Osborne AG. Diagnostic Neuroradiology. Editorial Mosby; 1 edición. St. Louis, Estados Unidos America (MO). 1994.
Noujaim SE, Rossi MD, Rao SK, Cacciarelli AA, Mendonca RA, Wang AM et al. CT and MR Imaging of neurocysticercosis. AJR Am J Roentgenol. 1999;173:1485-1490.
Castillo M. Imaging of neurocysticercosis. Semin Roentgenol.2004;39:465-473.
Sheth TN, Pilon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol. 1998;19:79-82.
Nash TE, Pretell EJ, Lezcano AG, Busto JA, Gilman RH, González AE, et al; Cysticercosis Working Group in Peru. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008; 7: 1099-1105.
Kalra V, Sethi A. Childhood neurocysticercosis epidemiology, diagnosis and course. Acta Paediatr Jpn 1992;34:365-370
Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57: 177–183.
Sotello J, Del Brutto O. Therapy of Neurocysticercosis in Childs - Nerv Sist 1987; 3: 208-211.
Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial.J.Pediatr.2003;143:111-114.
Carpio A, Kelvin EA, Bagiella E, Leslie D. The Ecuadonan Neurocysticercosis Group. Effects of albendazole treatment on neurocysticercosis: A randomized controlled trial.J.Neurol Neurosurg Psyshiatry.2008;79:1050-1055.
Thakur C, Anand K. Childhood Neurocysticercosis in South India. Ind. J. Ped. 1991; 58: 805-9.
Kalra V. Sethia - Chilhood Neurocysticercosis Epidemiolog, Diagnosis and course. act. Pedia JPS 1992; 34: 365-70.
Sotello J, del Brutto O. Therapy of Neurocysticercosis in Childs - Nerv Sist 1987; 3: 208-11
Cutter AC. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2003; 60: 1873-4.
Fernández R, Ortiz R, Pío A, Peña A. Alternativas quirúrgicas en el tratamiento de la neurocisticercosis. Rev. neuropsiquiatr 2005; 68:153-171.
Colli B, Martelli N, Machado H, Salvarani C, Sassoli V, Forjaz S. Cysticercosis of the central nervous system I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School. Arq Neuropsiquiatr 1994;52(2):166-186.
Sciutto E, Fragoso G. Vaccine:Cysticercosis. Vaccine 2005; 23: 4062-4064.
Huerta M., A. S. de Aluja G, Fragoso A, Toledo N, Villalobos M, Hernández G. “Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico”, Vaccine 2005; 20:262-266.
Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimora S.Neurocysticercosis in children: clinical study and follow-up of 112 patients. Rev Neurol 2006; 42 (Supl 3): 97-101.
Sighi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Chil Neurol 2000; 15: 207-13.
Fleury A, Gómez I, Álvarez D,Meza M, Huerta A, Chavarría R. “High prevalence of calcified silent neurocysticercosis in a rural village of Mexico”, Neuroepidemiology 2003; 22: 139-145.
dc.rights.spa.fl_str_mv Revista Ciencias Biomédicas - 2020
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv Revista Ciencias Biomédicas - 2020
https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad de Cartagena
dc.source.spa.fl_str_mv https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3069
institution Universidad de Cartagena
bitstream.url.fl_str_mv https://repositorio.unicartagena.edu.co/bitstreams/2caccd31-6aa1-48af-a2a1-334bda3d9f0a/download
bitstream.checksum.fl_str_mv 0b210bd7c83a7714b44145bb1eefb5cb
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1814214199679647744
spelling González Velásquez, TaniaBarboza Ubarnes, Miriam2020-12-21 00:00:002020-12-21 00:00:002020-12-212215-7840https://hdl.handle.net/11227/1333810.32997/rcb-2011-30692389-7252https://doi.org/10.32997/rcb-2011-3069application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3069/2600Núm. 2 , Año 201129622892Garcia H, Brutto O. For the cisticercosis working Groupin Perú. Neurocysticercosis:Updated concepts about and old disease. Lancet Neurol 2005;4: 653-61.Agudelo P, Botero D, Palacio G. Evaluación del método de ELISA de punto para el diagnóstico de la cisticercosis humana y para estimar valores de prevalencia en una región endémica en Colombia. Biomédica. 2005; 25: 40-43.Flórez AC, Rojas R, Montero YA. Estudio retrospectivo de seroprevalencia de Neurocisticercosis en pacientes colombianos que acudieron al Instituto Nacional de Salud, durante un período de 10 años (1995 – 2005). Programa de Vigilancia por el Laboratorio. Infectio 2006 10(2): 98Bonelo A, Carvajal H. Cisticercosis en pacientes con cuadro neurológico en Cali, Facultad de Salud, Universidad del Valle, Cali. Biomédica. Santa Fe de Bogotá Suplemento jul. 1993; 96Vasquez L, Ortiz J, Velasco A, González F. Neurocisticercosis: casos clínicos presentes en el hospital universitario San José Popayán, 1994 – 1999. Infect. 2000, 4, (1): 51-52.Sanzón A. Prevalencia de anticuerpos contra cisticercos. Colombia médica Cali, 1991; 22: 98- 100.Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-1734.Giménez-Roldán S, Díaz F, Esquivel A. Neurocisticercosis e inmigración. Neurología 2003; 18: 385-388.Pal DK, Carpio A, Sander JWAS. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000; 68; 137-143.Kalra V, Sethi A. childhood neurocysticercosis – epidemiology diagnosis and course. Acta Peaditr Jpn, 1992, 34 :365-70Aguilar F. Perfil de la neurocisticercosis en niños mexicanos. Cir Ciruj 1998; 66:86-89.Gaffo AL, Guillen-Pinto D, Campos-Olazábal P, Burneo JG. Cisticercosis, la causa principal de crisis parciales en niños en Peru. Rev Neurol 2004; 39: 924-926.Hauser WA, Pellock JM Dodson WE. Epidemiology of epilepsy in children. Pediatric epilepsy: diagnosis and therapy. 2001;12: 81-96.Carod-Artal F. Causas tropicales de epilepsia.Rev Neurol 2009;49:475-82Botero D, Restrepo M. Parasitosis humana. Editorial Colombia Corporación Para La Investigaciones Biológicas; 4rt edición. Medellín, Colombia.2003.Sighi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Chil Neurol 2000; 15: 207-213.Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimora S. Neurocysticercosis in children: clinical study and follow-up of 112 patients. Rev Neurol 2006; 42 Supl 3: 97-101.Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM. Clinical aspects of neurocisticercosis in children. Pediatr Neurol 2000; 22: 287-289.Ruiz-García M. Neurocysticercosis in children. Clinical experience in 122 patients. Child Nerv Syst 1997; 13: 608-612.Cuéllar R, Molinero M, Ramírez F, Vallejo V. Manifestaciones clínicas de la neurocisticercosis cerebral activa en pediatría. Rev Neurol 1999; 29: 334-337.Osborne AG. Diagnostic Neuroradiology. Editorial Mosby; 1 edición. St. Louis, Estados Unidos America (MO). 1994.Noujaim SE, Rossi MD, Rao SK, Cacciarelli AA, Mendonca RA, Wang AM et al. CT and MR Imaging of neurocysticercosis. AJR Am J Roentgenol. 1999;173:1485-1490.Castillo M. Imaging of neurocysticercosis. Semin Roentgenol.2004;39:465-473.Sheth TN, Pilon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol. 1998;19:79-82.Nash TE, Pretell EJ, Lezcano AG, Busto JA, Gilman RH, González AE, et al; Cysticercosis Working Group in Peru. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008; 7: 1099-1105.Kalra V, Sethi A. Childhood neurocysticercosis epidemiology, diagnosis and course. Acta Paediatr Jpn 1992;34:365-370Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57: 177–183.Sotello J, Del Brutto O. Therapy of Neurocysticercosis in Childs - Nerv Sist 1987; 3: 208-211.Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial.J.Pediatr.2003;143:111-114.Carpio A, Kelvin EA, Bagiella E, Leslie D. The Ecuadonan Neurocysticercosis Group. Effects of albendazole treatment on neurocysticercosis: A randomized controlled trial.J.Neurol Neurosurg Psyshiatry.2008;79:1050-1055.Thakur C, Anand K. Childhood Neurocysticercosis in South India. Ind. J. Ped. 1991; 58: 805-9.Kalra V. Sethia - Chilhood Neurocysticercosis Epidemiolog, Diagnosis and course. act. Pedia JPS 1992; 34: 365-70.Sotello J, del Brutto O. Therapy of Neurocysticercosis in Childs - Nerv Sist 1987; 3: 208-11Cutter AC. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2003; 60: 1873-4.Fernández R, Ortiz R, Pío A, Peña A. Alternativas quirúrgicas en el tratamiento de la neurocisticercosis. Rev. neuropsiquiatr 2005; 68:153-171.Colli B, Martelli N, Machado H, Salvarani C, Sassoli V, Forjaz S. Cysticercosis of the central nervous system I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School. Arq Neuropsiquiatr 1994;52(2):166-186.Sciutto E, Fragoso G. Vaccine:Cysticercosis. Vaccine 2005; 23: 4062-4064.Huerta M., A. S. de Aluja G, Fragoso A, Toledo N, Villalobos M, Hernández G. “Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico”, Vaccine 2005; 20:262-266.Antoniuk S, Bruck I, Santos LH, Souza LP, Fugimora S.Neurocysticercosis in children: clinical study and follow-up of 112 patients. Rev Neurol 2006; 42 (Supl 3): 97-101.Sighi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Chil Neurol 2000; 15: 207-13.Fleury A, Gómez I, Álvarez D,Meza M, Huerta A, Chavarría R. “High prevalence of calcified silent neurocysticercosis in a rural village of Mexico”, Neuroepidemiology 2003; 22: 139-145.Revista Ciencias Biomédicas - 2020https://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3069Cisticercosis. Neurocisticercosis. Taenia solium.Neurocisticercosis en niñosNeurocisticercosis en niñosArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2430https://repositorio.unicartagena.edu.co/bitstreams/2caccd31-6aa1-48af-a2a1-334bda3d9f0a/download0b210bd7c83a7714b44145bb1eefb5cbMD5111227/13338oai:repositorio.unicartagena.edu.co:11227/133382024-09-05 15:30:47.755https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Ciencias Biomédicas - 2020metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Publicaciones similares